Fig. 1From: RETRACTED ARTICLE: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trialSchematic illustration of the study design and patient selection. Safety set: the patients who received the assigned treatment at least once; FAS: full analysis set, the patients who provided data for evaluating the primary efficacy; PPS: per protocol set, the patients who completed the treatment without violation; CN: 0.05% cyclosporine nanoemulsion; DQ: 3% diquafosolBack to article page